Screening for kidney cancer has been identified as a research priority by several independent initiatives. Previous work revealed that the relatively low prevalence of kidney cancer in untargeted asymptomatic individuals hinders the cost-effectiveness and clinical utility of population screening. We therefore undertake a comprehensive literature review summarising novel screening concepts beyond whole population screening, including: targeting high-risk populations (to increase disease prevalence), screening for kidney cancer in combination with other abdominal conditions (to reduce costs), or combining both these approaches.
Kidney International published a clinical update in Research Highlights on 15 Apr 2026. The item focuses on Kidney cancer screening – novel concepts beyond population level screening. Open the detail page to review the full original feed content.